These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 812037)

  • 1. [Plan of hygiene in infection with Pseudomonas aeruginosa (B. pyocyaneum)].
    Eigenthaler G
    Osterr Krankenpflegez; 1975; 28(12):337-9. PubMed ID: 812037
    [No Abstract]   [Full Text] [Related]  

  • 2. [Proceedings: II. Pyocyaneus infection. a. Prevention and therapy. Significance of Bacterium pyocyaneum (Ps. aeruginosa) from the bacteriologic viewpoint].
    Linzenmeier G
    Hefte Unfallheilkd; 1973; 114():123-7. PubMed ID: 4205706
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of DNA fingerprinting in decision making for considering closure of neonatal intensive care units because of Pseudomonas aeruginosa bloodstream infections.
    Schutze GE; Gilliam CH; Jin S; Cavenaugh CK; Hall RW; Bradsher RW; Jacobs RF
    Pediatr Infect Dis J; 2004 Feb; 23(2):110-4. PubMed ID: 14872174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pseudomonas aeruginosa (Bacterium pyocyaneum) infection].
    Wöckel W
    Ergeb Allg Pathol Pathol Anat; 1967; 48():102-70. PubMed ID: 4960402
    [No Abstract]   [Full Text] [Related]  

  • 5. [Iatrogenic Pseudomonas aeruginosa infections].
    van Beusekom JA
    Ned Tijdschr Geneeskd; 1966 Sep; 110(38):1657-8. PubMed ID: 4962660
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
    Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
    Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hygienic significance of Pseudomonas aeruginosa in water].
    Rozhavin MA
    Gig Sanit; 1986 Jan; (1):41-2. PubMed ID: 3081409
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hospitalism caused by Pseudomonas aeruginosa].
    Schiek W
    Med Monatsschr; 1968 Apr; 22(4):163-7. PubMed ID: 4973237
    [No Abstract]   [Full Text] [Related]  

  • 9. [On pseudomonas aeruginosa infection].
    Steiner B; Putnoky G; Dobos A
    Orv Hetil; 1969 Aug; 110(33):1897-902. PubMed ID: 4980454
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hygiene and wound bacteriology].
    Fromantin I
    Soins; 2006 Oct; (709):19-20, 22. PubMed ID: 17111861
    [No Abstract]   [Full Text] [Related]  

  • 11. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pseudomonas aeruginosa - typing methods and hospital infections].
    Bergan T
    Nord Med; 1968 Apr; 79(16):505-8. PubMed ID: 4968666
    [No Abstract]   [Full Text] [Related]  

  • 13. [Is the a connection between prolonged carriage and clonal hospital-to-hospital clonal spread of multiresistant Pseudomonas aeruginosa of the O12 serotype? Are the specific habits of the hospitals involved the cause?].
    Watine J; Hacini J; Vidal I
    Pathol Biol (Paris); 1999 May; 47(5):457-61. PubMed ID: 10418018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigation on the protection of mice from infection with Pseudomonas aeruginosa using monoclonal antibodies].
    Ye DN; Wang CX; Yan RH; Dai BM; Ni HY
    Sichuan Yi Xue Yuan Xue Bao; 1985 Sep; 16(3):188-90. PubMed ID: 3939267
    [No Abstract]   [Full Text] [Related]  

  • 15. Segregation and use of nonshared care settings reduce the risk of multiresistant P. aeruginosa infection. Re: Davies et al., "Multiresistant Pseudomonas aeruginosa in a pediatric cystic fibrosis center: natural history and implications for segregation," Pediatr Pulmonol 2003;35:253-256.
    Festini F; Ballarin S; Loganes C
    Pediatr Pulmonol; 2003 Aug; 36(2):171; author reply 172. PubMed ID: 12833499
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pseudomonas aeruginosa infection in cystic fibrosis. The importance of early antibiotic therapy].
    Dutau G; Brémont F
    Rev Mal Respir; 1990; 7(3):183-5. PubMed ID: 2114027
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of using a polyvalent vaccine against Pseudomonas aeruginosa in patients with burns treated at various therapeutic centers in Poland].
    Bukowska D; Serafińska D; Zietkiewicz W; Rudowski W; Hoffman S; Uszyński H; Molski M; Hess C; Jonecko A; Popiel D
    Pol Tyg Lek; 1986 Dec; 41(49):1549-52. PubMed ID: 3108869
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the isolation of an infection-protective antigen from Psudomonas aeruginosa.
    Alexander JW; Brown W; Walker H; Mason AD; Moncrief JA
    Surg Gynecol Obstet; 1966 Nov; 123(5):965-77. PubMed ID: 4959020
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of a polyvalent vaccine against Pseudomonas aeruginosa in severely burned patients].
    Nasiłowski W; Zietkiewicz W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Rudowski W
    Pol Tyg Lek; 1984 Apr; 39(17):557-61. PubMed ID: 6435103
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunological control of pseudomonas infection in burns.
    R I Med J; 1972 Mar; 55(3):88. PubMed ID: 4622683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.